Site Search

... patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage ... classes, which cover drugs for cancer, epilepsy, HIV/AIDS, mental illness and organ transplants. However, last November the Department of Health and Human Services (HHS) announced a proposal to allow health plan administrators to extend the use of utilization management tools, like pre-authorization and step therapy, to protected class drug ...

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN). ... therapy selection and helping to monitor disease trajectory. Accuracy and reliability of diagnostic tests are the bedrock of any personalized care and are especially important in cancer where test results often drive life or death treatment decisions. “FDA has been judicious in its ...

Dr. Otis Brawley, Chief Medical Officer of the American Cancer Society, testified before the U.S. House Energy and Commerce Committee's Health Subcommittee on the importance of education and awareness in the fight to defeat breast cancer. The hearing focused on legislation related to improving breast cancer early detection, research, treatment, and quality of care. Introduced by Reps. Wasserman Schultz and Myrick in the House and Sens. Klobuchar and Olympia Snowe (R-Maine) in the Senate, the EARLY Act (H.R. 1740 and S. 994) would help young women understand the importance of breast health and the risks associated with breast cancer. Š—“As we recognize Breast Cancer Awareness Month this month, it is important to remember ...

WASHINGTON, D.C.—Cancer advocates are urging Congress to prioritize cancer prevention, detection, research and palliative care in any forthcoming year-end legislative package as a way to accelerate progress against the disease and end cancer as we know it. In a letter ... this year. The letter urges Congress to: Allocate a $4.1 billion increase in federal funding for research at the National Institutes of Health (NIH), including a $853 million increase for the National Cancer Institute (NCI) and a $72.8 million boost for the Centers for Disease ... multi-cancer early detection tests once the Food and Drug Administration approves their use and clinical benefit is shown. Pass the Palliative Care and Hospice Education Act, to improve patient quality of life by increasing access to services that address the entire continuum of patient ...